Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling

Abstract Mechanical forces of the tumor microenvironment change dynamically during key events of tumorigenesis such as invasion and metastasis. These changes in compressive forces often affect the breast cancer cell phenotype. However, it is lesser known how these dynamic mechanical forces in the tu...

Full description

Saved in:
Bibliographic Details
Main Authors: Aino Peura, Rita Turpin, Ruixian Liu, Maria Heilala, Maria Salmela, July Aung, Piia Mikkonen, Minna Mutka, Panu E. Kovanen, Laura Niinikoski, Tuomo Meretoja, Johanna Mattson, Päivi Heikkilä, Päivi Palanne, Tiina Kantanen, Mikko Kilpeläinen, Outi Ukkonen, Maija Hollmén, Topi A. Tervonen, Juha Klefström, Pauliina M. Munne
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-60092-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850242874821574656
author Aino Peura
Rita Turpin
Ruixian Liu
Maria Heilala
Maria Salmela
July Aung
Piia Mikkonen
Minna Mutka
Panu E. Kovanen
Laura Niinikoski
Tuomo Meretoja
Johanna Mattson
Päivi Heikkilä
Päivi Palanne
Tiina Kantanen
Mikko Kilpeläinen
Outi Ukkonen
Maija Hollmén
Topi A. Tervonen
Juha Klefström
Pauliina M. Munne
author_facet Aino Peura
Rita Turpin
Ruixian Liu
Maria Heilala
Maria Salmela
July Aung
Piia Mikkonen
Minna Mutka
Panu E. Kovanen
Laura Niinikoski
Tuomo Meretoja
Johanna Mattson
Päivi Heikkilä
Päivi Palanne
Tiina Kantanen
Mikko Kilpeläinen
Outi Ukkonen
Maija Hollmén
Topi A. Tervonen
Juha Klefström
Pauliina M. Munne
author_sort Aino Peura
collection DOAJ
description Abstract Mechanical forces of the tumor microenvironment change dynamically during key events of tumorigenesis such as invasion and metastasis. These changes in compressive forces often affect the breast cancer cell phenotype. However, it is lesser known how these dynamic mechanical forces in the tumor microenvironment affect the phenotypes of tumor infiltrated leukocytes (TIL) and their subsequent anticancer activities. Here we find, in primary patient-derived explant cultures (PDEC) containing resident TILs, that low compression promotes a change in the original identity of breast cancer cells from luminal to a more mesenchymal and undifferentiated state. These altered tumor cells induce an upregulation of immunosuppressive cytokines such as interleukin-10 (IL-10) and Transforming Growth Factor Beta (TGF-β), as well as polarization of macrophages towards pro-tumor M2(Gc)-type and depletion of CD8+ effector memory T-cells. These immunosuppressive events are mediated by tumor cell derived fibroblast growth factor 2 (FGF2) and prostaglandin E2 (PGE2). We also find that FGF2 rich areas in primary tumors show enrichment in M2-like-macrophages and diminished numbers of CD8 + T and B-cells. Our results suggest that low compressive forces in the tumor microenvironment induce local immunosuppression via FGF2 secretion arising from phenotypic plasticity of tumor cells.
format Article
id doaj-art-3b5b83b5b06e456d91570d268faa2ade
institution OA Journals
issn 2041-1723
language English
publishDate 2025-05-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-3b5b83b5b06e456d91570d268faa2ade2025-08-20T02:00:09ZengNature PortfolioNature Communications2041-17232025-05-0116111710.1038/s41467-025-60092-xSoft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signalingAino Peura0Rita Turpin1Ruixian Liu2Maria Heilala3Maria Salmela4July Aung5Piia Mikkonen6Minna Mutka7Panu E. Kovanen8Laura Niinikoski9Tuomo Meretoja10Johanna Mattson11Päivi Heikkilä12Päivi Palanne13Tiina Kantanen14Mikko Kilpeläinen15Outi Ukkonen16Maija Hollmén17Topi A. Tervonen18Juha Klefström19Pauliina M. Munne20Cancer Cell Circuitry Laboratory, Translational Cancer Medicine Research Program, Research Programs Unit, & Medicum, University of HelsinkiCancer Cell Circuitry Laboratory, Translational Cancer Medicine Research Program, Research Programs Unit, & Medicum, University of HelsinkiCancer Cell Circuitry Laboratory, Translational Cancer Medicine Research Program, Research Programs Unit, & Medicum, University of HelsinkiDepartment of Applied Physics, Aalto UniversityFinnish Genome Editing Center, HiLIFE infrastructures, University of Helsinki and Biocenter FinlandCancer Cell Circuitry Laboratory, Translational Cancer Medicine Research Program, Research Programs Unit, & Medicum, University of HelsinkiUPM Biomedicals, UPM-Kymmene CorporationDepartment of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of HelsinkiDepartment of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of HelsinkiBreast Surgery Unit, Comprehensive Cancer Center, Helsinki University Hospital and University of HelsinkiBreast Surgery Unit, Comprehensive Cancer Center, Helsinki University Hospital and University of HelsinkiComprehensive Cancer Center, University of Helsinki & Helsinki University HospitalDepartment of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of HelsinkiDepartment of Surgery, Kymenlaakso Central Hospital, KYMSOTEDepartment of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of HelsinkiDepartment of Surgery, Kymenlaakso Central Hospital, KYMSOTEDepartment of Surgery, Kymenlaakso Central Hospital, KYMSOTEMedicity Research Laboratory, University of Turku, Tykistökatu 6ACancer Cell Circuitry Laboratory, Translational Cancer Medicine Research Program, Research Programs Unit, & Medicum, University of HelsinkiCancer Cell Circuitry Laboratory, Translational Cancer Medicine Research Program, Research Programs Unit, & Medicum, University of HelsinkiCancer Cell Circuitry Laboratory, Translational Cancer Medicine Research Program, Research Programs Unit, & Medicum, University of HelsinkiAbstract Mechanical forces of the tumor microenvironment change dynamically during key events of tumorigenesis such as invasion and metastasis. These changes in compressive forces often affect the breast cancer cell phenotype. However, it is lesser known how these dynamic mechanical forces in the tumor microenvironment affect the phenotypes of tumor infiltrated leukocytes (TIL) and their subsequent anticancer activities. Here we find, in primary patient-derived explant cultures (PDEC) containing resident TILs, that low compression promotes a change in the original identity of breast cancer cells from luminal to a more mesenchymal and undifferentiated state. These altered tumor cells induce an upregulation of immunosuppressive cytokines such as interleukin-10 (IL-10) and Transforming Growth Factor Beta (TGF-β), as well as polarization of macrophages towards pro-tumor M2(Gc)-type and depletion of CD8+ effector memory T-cells. These immunosuppressive events are mediated by tumor cell derived fibroblast growth factor 2 (FGF2) and prostaglandin E2 (PGE2). We also find that FGF2 rich areas in primary tumors show enrichment in M2-like-macrophages and diminished numbers of CD8 + T and B-cells. Our results suggest that low compressive forces in the tumor microenvironment induce local immunosuppression via FGF2 secretion arising from phenotypic plasticity of tumor cells.https://doi.org/10.1038/s41467-025-60092-x
spellingShingle Aino Peura
Rita Turpin
Ruixian Liu
Maria Heilala
Maria Salmela
July Aung
Piia Mikkonen
Minna Mutka
Panu E. Kovanen
Laura Niinikoski
Tuomo Meretoja
Johanna Mattson
Päivi Heikkilä
Päivi Palanne
Tiina Kantanen
Mikko Kilpeläinen
Outi Ukkonen
Maija Hollmén
Topi A. Tervonen
Juha Klefström
Pauliina M. Munne
Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling
Nature Communications
title Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling
title_full Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling
title_fullStr Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling
title_full_unstemmed Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling
title_short Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling
title_sort soft matrix promotes immunosuppression in tumor resident immune cells via cox fgf2 signaling
url https://doi.org/10.1038/s41467-025-60092-x
work_keys_str_mv AT ainopeura softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT ritaturpin softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT ruixianliu softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT mariaheilala softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT mariasalmela softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT julyaung softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT piiamikkonen softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT minnamutka softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT panuekovanen softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT lauraniinikoski softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT tuomomeretoja softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT johannamattson softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT paiviheikkila softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT paivipalanne softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT tiinakantanen softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT mikkokilpelainen softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT outiukkonen softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT maijahollmen softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT topiatervonen softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT juhaklefstrom softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling
AT pauliinammunne softmatrixpromotesimmunosuppressionintumorresidentimmunecellsviacoxfgf2signaling